Deccan Cements Ltd. — Major Shareholding Notification 2025

Nov 13, 2025

==> picture [157 x 56] intentionally omitted <==

==> picture [199 x 53] intentionally omitted <==

BSE Limited 25[th] Floor, Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001 India

Fax: +91 22 2272 1919 Tel: +91 22 2272 1233 / 4, +91 22 6654 5695

13 Nov 2025

Dear Sir/Madam:

Enclosed please find a copy of regulatory filings for DECCAN CEMENTS LIMITED

• Regulatory filing required under regulation 29 (2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 2011

Should you have any questions, please contact us at email apac.regulatory.filings@fil.com or via Fax on +86 411 3971 6222 .

Yours faithfully,

==> picture [117 x 64] intentionally omitted <==

Alina Yu Regulatory Reporting Manager

Encl.

==> picture [195 x 69] intentionally omitted <==

Format for disclosures under Regulation 29(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

	Name of the Target Company (TC)	DECCAN CEMENTS LIMITED	DECCAN CEMENTS LIMITED	DECCAN CEMENTS LIMITED
	Name(s) of the acquirer and Persons Acting in Concert (PAC) with the acquirer	See attached Schedule for breakdown of funds under the management of FMR LLC and its direct and indirect subsidiaries and FIL Limited and its direct and indirect subsidiaries
	Whether the acquirer belongs to Promoter/Promoter group	No
	Name(s) of the Stock Exchange(s) where the shares of TC are Listed	National Stock Exchange of India Ltd. BSE Ltd
	Details of the acquisition /disposal as follows	Number	% w.r.t.total share/voting capital wherever applicable ~~(~~*~~)~~	% w.r.t. total diluted share/voting capital of the TC (**)
	Before the acquisition/disposal under consideration, holding of : a) Shares carrying voting rights	705,239	5.035%	N/A
	b) Shares in the nature of encumbrance (pledge/ lien/ non- disposal undertaking/ others)
	c) Voting rights (VR) otherwise than by shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the T C (specify holding in each category) e) Total (a+b+c+d)	705,239	5.035%	N/A
	Details of acquisition/sale a) Shares carrying voting rights acquired/sold b) VRs acquired /sold otherwise than by shares c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold	284,663	2.03%	N/A
	d) Shares encumbered / invoked/released bythe acquirer
	e)Total(a+b+c+/-d)	284,663	2.03%	N/A

==> picture [188 x 68] intentionally omitted <==

After the acquisition/sale, holding of: a) Shares carrying voting rights b) Shares encumbered with the acquirer c) VRs otherwise than by shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition e) Total (a+b+c+d)	989,902 989,902	7.07% 7.07%	N/A N/A
Mode of acquisition / sale (e.g. open market / off-market / public issue / rights issue / preferential allotment / inter-se transfer etc).	Open Market
Date of acquisition / sale of shares / VR or date of receipt of intimation of allotment of shares, whichever is applicable	22 Nov 2023- 11 Nov 2025
Equity share capital / total voting capital of the TC before the said acquisition / sale	14,007,500
Equity share capital/ total voting capital of the TC after the said acquisition / sale	14,007,500
Total diluted share/voting capital of the TC after the said acquisition/sale	N/A

(*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement.

(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

Signature of the acquirer / seller / Authorised

==> picture [76 x 38] intentionally omitted <==

Alina Yu Regulatory Reporting Manager

Duly authorized under Powers of Attorney by and on behalf of FMR LLC & FIL Limited

Signatory Place: Unit 601, 6th Floor, No. 12 Building, No. 21 Software Park Road East, Dalian 116023, People's Republic of China

Date: 13 Nov 2025

==> picture [198 x 68] intentionally omitted <==

Schedule

	Schedule
	Fund	FPI	Shares Held	% of shares and voting rights held
Funds under the management of FMR LLC and its direct and indirect subsidiaries and FIL Limited and its direct and indirect subsidiaries	Fidelity Emerging Markets Discovery Fund	INUSFP303316	693,039	4.95
	Fidelity Emerging Markets Value Advance Equity Mother Fund	INJPFP048024	296,863	2.12
Total			989,902	7.07